Increased risk of thyroid pathology in patients with thyroid hemiagenesis: Results of a large cohort case-control study

European Journal of Endocrinology

Volumn 162, Issue 1, 2010, Pages 153-160

  Ruchala, Marek ^a   Szczepanek, Ewelina ^a   Szaflarski, Witold ^a   Moczko, Jerzy ^a   Czarnywojtek, Agata ^a   Pietz, Leszek ^a   Nowicki, Michal ^a   Niedziela, Marek ^a   Zabel, Maciej ^a   Köhrle, Josef ^b   Sowinski, Jerzy ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IODINE 131; IODOTHYRONINE; LEVOTHYROXINE; TECHNETIUM 99M; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; CONTROL GROUP; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; THYROID DISEASE; THYROID DYSGENESIS; THYROID HEMIAGENESIS; THYROID SCINTISCANNING; THYROTROPIN BLOOD LEVEL; TREATMENT INDICATION; ADOLESCENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONGENITAL MALFORMATION; CONTROLLED CLINICAL TRIAL; CROSS-SECTIONAL STUDY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCINTISCANNING; THYROID GLAND;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; THYROID DYSGENESIS; THYROID GLAND; YOUNG ADULT;

EID: 73949154411     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0590     Document Type: Article

References (34)

1. McHenry CR, Walfish PG, Rosen IB, Lawrence AM & Paloyan E. Congenital thyroid hemiagenesis. American Surgeon 1995 61 634-638 (discussion 638-639).
2. Shabana W, Delange F, Freson M, Osteaux M & De Schepper J. Prevalence of thyroid hemiagenesis: ultrasound screening in normal children. European Journal of Pediatrics 2000 159 456-458.
3. Mikosch P, Gallowitsch HJ, Kresnik E, Molnar M, Gomez I & Lind P. Thyroid hemiagenesis in an endemic goiter area diagnosed by ultrasonography: report of sixteen patients. Thyroid 1999 9 1075-1084.
4. Pizzini AM, Papi G, Corrado S, Carani C & Roti E. Thyroid hemiagenesis and incidentally discovered papillary thyroid cancer: case report and review of the literature. Journal of Endocrinological Investigation 2005 28 66-71.
5. Park IH, Kwon SY, Jung KY & Woo JS. Thyroid hemiagenesis: clinical significance in the patient with thyroid nodule. Journal of Laryngology and Otology 2006 120 605-607.
6. Maiorana R, Carta A, Floriddia G, Leonardi D, Buscema M, Sava L, Calaciura F & Vigneri R. Thyroid hemiagenesis: prevalence in normal children and effect on thyroid function. Journal of Clinical Endocrinology and Metabolism 2003 88 1534-1536.
7. Deladoey J, Vassart G & Van Vliet G. Possible non-Mendelian mechanisms of thyroid dysgenesis. Endocrine Development 2007 10 29-42.
8. Tsang SK & Maher J. Thyroid hemiagenesis accompanying a thyroglossal duct cyst: a case report. Clinical Nuclear Medicine 1998 23 229-232.
9. Sharma R, Mondal A, Popli M, Sahoo M, Malhotra N & Soni S. Hemiagenesis of the thyroid associated with chronic lymphocytic thyroiditis. Clinical Nuclear Medicine 2001 26 506-508.
10. Nakamura S, Isaji M & Ishimori M. Thyroid hemiagenesis with postpartum silent thyroiditis. Internal Medicine 2004 43 306-309.
11. Ozgen AG, Saygili F & Kabalak T. Thyroid hemiagenesis associated with Graves' disease and Graves' ophthalmopathy: case report. Thyroid 2004 14 75-77.
12. Lee YS, Yun JS, Jeong JJ, Nam KH, Chung WY & Park CS. Thyroid hemiagenesis associated with thyroid adenomatous hyperplasia and papillary thyroid carcinoma. Thyroid 2008 18 381-382.
13. Ruchala M, Szczepanek E, Skiba A, Czepczynski R & Sowinski J. Graves' hyperthyroidism following primary hypothyroidism due to Hashimoto's thyroiditis in a case of thyroid hemiagenesis: case report. Neuroendocrinology Letters 2008 29 55-58.
14. Andersson M, Takkouche B, Egli I, Allen HE & de Benoist B. Current global iodine status and progress over the last decade towards the elimination of iodine deficiency. Bulletin of the World Health Organization 2005 83 518-525.
15. Korpal-Szczyrska M, Kosiak W & Swieton D. Prevalence of thyroid hemiagenesis in an asymptomatic school children population. Thyroid 2008 18 637-639.
16. Gursoy A, Anil C, Unal AD, Demirer AN, Tutuncu NB & Erdogan MF. Clinical and epidemiological characteristics of thyroid hemiagenesis: ultrasound screening in patients with thyroid disease and normal population. Endocrine 2008 33 338-341.
17. Melnick JC & Stemkowski PE. Thyroid hemiagenesis (hockey stick sign): a review of the world literature and a report of four cases. Journal of Clinical Endocrinology and Metabolism 1981 52 247-251.
18. Mariani G, Molea N, Toni MG & Bianchi R. Thyroid hemiagenesis: a review of thirteen consecutive cases. Journal of Nuclear Medicine and Allied Sciences 1980 24 183-187.
19. Castanet M, Leenhardt L, Leger J, Simon-Carre A, Lyonnet S, Pelet A, Czernichow P & Polak M. Thyroid hemiagenesis is a rare variant of thyroid dysgenesis with a familial component but without Pax8 mutations in a cohort of 22 cases. Pediatric Research 2005 57 908-913.
20. Ramos HE, Nesi-Franca S, Boldarine VT, Pereira RM, Chiamolera MI, Camacho CP, Graf H, de Lacerda L, Carvalho GA & Maciel RM. Clinical and molecular analysis of thyroid hypoplasia: a population-based approach in Southern Brazil. Thyroid 2009 19 61-68.
21. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA & Stockigt JR. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003 13 3-126.
22. Volzke H, Alte D, Kohlmann T, Ludemann J, Nauck M, John U & Meng W. Reference intervals of serum thyroid function tests in a previously iodine-deficient area. Thyroid 2005 15 279-285.
23. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA & Braverman LE. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism 2002 87 489-499.
24. Warren RE, Perros P, Nyirenda MJ & Frier BM. Serum thyrotropin is a better predictor of future thyroid dysfunction than thyroid autoantibody status in biochemically euthyroid patients with diabetes: implications for screening. Thyroid 2004 14 853-857.
25. Pedrinola F, Rubio I, Santos CL & Medeiros-Neto G. Overexpression of epidermal growth factor and epidermal growth factorreceptor mRNAs in dyshormonogenetic goiters. Thyroid 2001 11 15-20.
26. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC & Franklyn JA. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. Journal of Clinical Endocrinology and Metabolism 2006 91 4295-4301.
27. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC & Chen H. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. Journal of Clinical Endocrinology and Metabolism 2008 93 809-814.
28. Weetman AP. The genetics of autoimmune thyroid disease. Hormone and Metabolic Research 2009 41 421-425.
29. Rapoport B & McLachlan SM. Thyroid autoimmunity. Journal of Clinical Investigation 2001 108 1253-1259.
30. Flynn JC, Gilbert JA, Meroueh C, Snower DP, David CS, Kong YC & Banga JP. Chronic exposure in vivo to thyrotropin receptor stimulating monoclonal antibodies sustains high thyroxine levels and thyroid hyperplasia in thyroid autoimmunity-prone HLA-DRB1* 0301 transgenic mice. Immunology 2007 122 261-267.
31. Szybinski Z, Delange F, Lewinski A, Podoba J, Rybakowa M, Wasik R, Szewczyk L, Huszno B, Golkowski F, Przybylik-Mazurek E, Karbownik M, Zak T, Pantoflinski J, Trofimiuk M & Kinalska I. A programme of iodine supplementation using only iodised household salt is efficient - the case of Poland. European Journal of Endocrinology 2001 144 331-337.
32. Baczyk M, Ruchala M, Pisarek M, Pietz L, Wrotkowska E, Wojewoda-Korbelak M, Dziubandowska A, Gembicki M & Sowinski J. Iodine prophylaxis in children population on the Wielkopolska Region area from year 1992 to 2005. Endokrynologia Polska 2006 57 110-115.
33. Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D, Jin Y, Yu X, Fan C, Chong W, Yang F, Dai H, Yu Y, Li J, Chen Y, Zhao D, Shi X, Hu F, Mao J, Gu X, Yang R, Tong Y, Wang W, Gao T & Li C. Effect of iodine intake on thyroid diseases in China. New England Journal of Medicine 2006 354 2783-2793.
34. Fountoulakis S, Philippou G & Tsatsoulis A. The role of iodine in the evolution of thyroid disease in Greece: from endemic goiter to thyroid autoimmunity. Hormones 2007 6 25-35.